Search Results - Sam Wilding

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Predicting the risk of childhood overweight and obesity at 4–5 years using population-level pregnancy and early-life healthcare data

    Predicting the risk of childhood overweight and obesity at 4–5 years using population-level pregnancy and early-life healthcare data by Nida Ziauddeen, Sam Wilding, Paul Roderick, Nicholas S. Macklon, Dianna Smith, Debbie Chase, Nisreen A Alwan

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    NSAID prescribing and adverse outcomes in common infections: a population-based cohort study

    NSAID prescribing and adverse outcomes in common infections: a population-based cohort study by Beth Stuart, Roderick P Venekamp, Hilda Hounkpatin, Sam Wilding, Michael Moore, Paul Little, Martin Gulliford

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial

    Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial by Simon J. Crabb, Gareth Griffiths, Denise Dunkley, Nichola Downs, Mary Ellis, Mike Radford, Michelle Light, Josh Northey, Amy Whitehead, Sam Wilding, Alison Birtle, Vincent Khoo, Robert J. Jones

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)

    Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID) by Simon J. Crabb, Gareth Griffiths, Ellice Marwood, Denise Dunkley, Nichola Downs, Karen Martin, Michelle Light, Josh Northey, Sam Wilding, Amy Whitehead, Emily Shaw, Alison Birtle, Amit Bahl, Tony Elliott, Charlotte Westbury, Santhanam Sundar, Angus Robinson, Satinder Jagdev, Satish Kumar, Claire Rooney, Carolina Salinas-Souza, Christine Stephens, Vincent Khoo, Robert J. Jones

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up

    Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up by Andrew Davies, Sharon Barrans, Louise Stanton, Josh Caddy, Sam Wilding, Geoff Saunders, Christoph Mamot, Urban Novak, Andrew McMillan, Paul Fields, Graham P. Collins, Richard Stephens, Francesco Cucco, Chulin Sha, Moniek van Hoppe, Reuben Tooze, John R. Davies, Gareth Griffiths, Anna Schuh, Catherine Burton, David R. Westhead, Ming‐Qing Du, Peter Johnson

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial

    Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial by Nick Curzen, Zoe Nicholas, Beth Stuart, Sam Wilding, Kayleigh Hill, James Shambrook, Zina Eminton, Darran Ball, Millie Barrett, Lucy Johnson, Jacqui Nuttall, Kim Fox, Derek Connolly, P. O’Kane, Alex Hobson, Anoop Chauhan, Neal Uren, Gerry P McCann, Colin Berry, Justin Carter, Carl Roobottom, Mamas A. Mamas, Ronak Rajani, Ian Ford, Pamela S. Douglas, Mark A. Hlatky

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: